Research and Markets: Plague Therapeutics Pipeline Review 2015 - 8 Companies & 9 Drug Profiles


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/jxcp4b/plague_pipeline) has announced the addition of the "Plague - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Plague, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Plague and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Aradigm Corporation
  • Cellceutix Corporation
  • Grifols, S.A.
  • iBio, Inc.
  • Mucosis B.V.
  • Summit Corporation plc
  • Syntiron LLC
  • Tetraphase Pharmaceuticals Inc.

Drug Profiles

  • anthrax + plague vaccine
  • ARD-3100
  • ciprofloxacin hydrochloride
  • PMX-30016
  • pneumonic plaque vaccine
  • Small Molecules to Inhibit Yoph Protein Tyrosine Phosphatase for Plague
  • SMT-15000
  • TP-271
  • yersinia pestis vaccine

For more information visit http://www.researchandmarkets.com/research/jxcp4b/plague_pipeline

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Press Releases